AXSM
Axsome Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$12.14B
P/E Ratio
—
EPS
$-3.73
Beta
0.58
52W High
$236.84
52W Low
$96.09
50-Day MA
$190.00
200-Day MA
$156.71
Dividend Yield
—
Profit Margin
-26.60%
Forward P/E
333.33
PEG Ratio
0.00
About Axsome Therapeutics Inc
Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $708.24M |
| Gross Profit (TTM) | $655.82M |
| EBITDA | $-167.23M |
| Operating Margin | -32.80% |
| Return on Equity | -349.40% |
| Return on Assets | -16.80% |
| Revenue/Share (TTM) | $14.07 |
| Book Value | $1.06 |
| Price-to-Book | 222.45 |
| Price-to-Sales (TTM) | 17.15 |
| EV/Revenue | 17.03 |
| EV/EBITDA | -14.81 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 57.40% |
| Shares Outstanding | $51.46M |
| Float | $43.55M |
| % Insiders | 15.38% |
| % Institutions | 76.80% |
Historical Volatility
HV 10-Day
33.80%
HV 20-Day
56.05%
HV 30-Day
48.98%
HV 60-Day
42.49%
HV Rank
82.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($270.28 target)
3
Strong Buy17
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026